TY - JOUR
T1 - Exercise training in advanced heart failure patients
T2 - Discordance between improved exercise tolerance and unchanged NT-proBNP levels
AU - Arad, Michael
AU - Adler, Yehuda
AU - Koren-Morag, Nira
AU - Natanzon, Shy
AU - Sela, Ben Ami
AU - Ben Dov, Issahar
AU - Shechter, Michael
AU - Schwammenthal, Ehud
AU - Freimark, Dov
PY - 2008/5/7
Y1 - 2008/5/7
N2 - Background: Exercise training can improve aerobic capacity and symptoms in congestive heart failure (CHF) patients. Aims: To test the feasibility of exercise training in advanced CHF patients, and examine the potential benefit from peripheral vascular and muscular conditioning as well as improved central hemodynamic and neurohumoral status. Methods and results: Thirty NYHA functional class III, CHF patients (mean age 61 ± 13 yr, ejection fraction 27 ± 4%, VO2max 11.3 ± 3.9 ml/kg/min) were enrolled. Exercise capacity, cardiovascular parameters and serum levels of brain natriuretic peptide (NT-proBNP) were determined at baseline and after 18 weeks of moderate intensity exercise training. Twenty eight (93%) patients, who completed the exercise program, experienced marked improvements in the 6 min walk (+ 39%) and exercise duration on the modified Bruce protocol (+ 66%). Smaller improvements were recorded in the cardiac index (a 15% increase), in the maximal oxygen consumption (a 13% increase in VO2max), in the left ventricular ejection fraction (an 11% increase) and in the systemic vascular resistance and pulmonary artery pressure (an 11% decrease). NT-proBNP levels were not significantly affected. They correlated with exercise capacity and VO2max on baseline measurement, but these correlations were not found after training. Conclusion: Rehabilitation is feasible, even in advanced CHF, and leads to markedly improved exercise performance, but does not affect the level of the principal neurohumoral marker of prognosis - NT-proBNP. Resting cardiovascular performance and maximal oxygen consumption improve less than functional capacity, suggesting that an important benefit is derived from muscle conditioning and improved peripheral vascular response to exercise.
AB - Background: Exercise training can improve aerobic capacity and symptoms in congestive heart failure (CHF) patients. Aims: To test the feasibility of exercise training in advanced CHF patients, and examine the potential benefit from peripheral vascular and muscular conditioning as well as improved central hemodynamic and neurohumoral status. Methods and results: Thirty NYHA functional class III, CHF patients (mean age 61 ± 13 yr, ejection fraction 27 ± 4%, VO2max 11.3 ± 3.9 ml/kg/min) were enrolled. Exercise capacity, cardiovascular parameters and serum levels of brain natriuretic peptide (NT-proBNP) were determined at baseline and after 18 weeks of moderate intensity exercise training. Twenty eight (93%) patients, who completed the exercise program, experienced marked improvements in the 6 min walk (+ 39%) and exercise duration on the modified Bruce protocol (+ 66%). Smaller improvements were recorded in the cardiac index (a 15% increase), in the maximal oxygen consumption (a 13% increase in VO2max), in the left ventricular ejection fraction (an 11% increase) and in the systemic vascular resistance and pulmonary artery pressure (an 11% decrease). NT-proBNP levels were not significantly affected. They correlated with exercise capacity and VO2max on baseline measurement, but these correlations were not found after training. Conclusion: Rehabilitation is feasible, even in advanced CHF, and leads to markedly improved exercise performance, but does not affect the level of the principal neurohumoral marker of prognosis - NT-proBNP. Resting cardiovascular performance and maximal oxygen consumption improve less than functional capacity, suggesting that an important benefit is derived from muscle conditioning and improved peripheral vascular response to exercise.
KW - Advanced heart failure
KW - Exercise capacity
KW - NT-proBNP
KW - Rehabilitation
UR - http://www.scopus.com/inward/record.url?scp=41949096077&partnerID=8YFLogxK
U2 - 10.1016/j.ijcard.2007.05.005
DO - 10.1016/j.ijcard.2007.05.005
M3 - ???researchoutput.researchoutputtypes.contributiontojournal.article???
AN - SCOPUS:41949096077
SN - 0167-5273
VL - 126
SP - 114
EP - 119
JO - International Journal of Cardiology
JF - International Journal of Cardiology
IS - 1
ER -